Jack A. Khattar
CEO, President at Supernus Pharmaceuticals, Inc. (SUPN)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $7.2M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 16SEC | SUPNSupernus Pharmaceuticals, Inc. | Sell Plan | 24,138968,962 held (−2%) | $50.09 | $1.2M | -14.8% |
| Mar 16SEC | SUPNSupernus Pharmaceuticals, Inc. | Sell Plan | 10,742958,220 held (−1%) | $51.00 | $548K | -16.3% |
| Mar 16SEC | SUPNSupernus Pharmaceuticals, Inc. | Sell Plan | 120958,100 held (−0%) | $51.75 | $6K | -17.5% |
| Oct 10SEC | SUPNSupernus Pharmaceuticals, Inc. | Sell Plan | 58,3711,208,107 held (−5%) | $50.55 | $3.0M | -15.6% |
| Oct 10SEC | SUPNSupernus Pharmaceuticals, Inc. | Sell Plan | 1,5291,206,578 held (−0%) | $51.46 | $79K | -17.1% |
| Oct 3SEC | SUPNSupernus Pharmaceuticals, Inc. | Sell Plan | 1,9041,161,233 held (−0%) | $48.06 | $92K | -11.2% |
| Oct 2SEC | SUPNSupernus Pharmaceuticals, Inc. | Sell Plan | 40,1731,160,870 held (−3%) | $48.07 | $1.9M | -11.2% |
| Oct 1SEC | SUPNSupernus Pharmaceuticals, Inc. | Sell Plan | 8,5881,147,258 held (−1%) | $48.25 | $414K | -11.6% |
- Sell
CEO, President Jack A. Khattar sold $1.2M of SUPN at $50.09 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Jack A. Khattar sold $548K of SUPN at $51.00 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Jack A. Khattar sold $6K of SUPN at $51.75 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Jack A. Khattar sold $3.0M of SUPN at $50.55 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Jack A. Khattar sold $79K of SUPN at $51.46 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President Jack A. Khattar sold $92K of SUPN at $48.06 — pre-scheduled 10b5-1 plan sale.